Grail, Inc.(US:GRAL) Prnewswire·2026-02-16 14:00Core Insights - GRAIL, Inc. will announce its financial results for the fourth quarter and full year 2025 on February 19, 2026, after market close [1] - A webcast and conference call will be held at 2:00 p.m. PT / 5:00 p.m. ET to discuss the results and business progress [1] Company Overview - GRAIL is a healthcare company focused on early cancer detection, aiming to alleviate the global burden of cancer [1] - The company utilizes next-generation sequencing, population-scale clinical studies, and advanced machine learning to identify multiple cancer types at earlier stages [1] - GRAIL's platform supports various aspects of cancer care, including multi-cancer early detection, risk stratification, and treatment monitoring [1] - The company is headquartered in Menlo Park, California, with additional locations in Washington, D.C., North Carolina, and the United Kingdom [1]